CARDIZEM

This brand name is authorized in Australia, Brazil, Finland, New Zealand, United States

Active ingredients

The drug CARDIZEM contains one active pharmaceutical ingredient (API):

1 Diltiazem UNII OLH94387TE - DILTIAZEM HYDROCHLORIDE

Diltiazem is a calcium antagonist. It restricts the slow channel entry of calcium into the cell and so reduces the liberation of calcium from stores in the sarcoplasmic reticulum. This results in a reduction of the amount of available intracellular calcium reducing myocardial oxygen consumption. Read about Diltiazem

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CARDIZEM CD Extended-release capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08DB01	Diltiazem	C Cardiovascular system → C08 Calcium channel blockers → C08D Selective calcium channel blockers with direct cardiac effects → C08DB Benzothiazepine derivatives
Discover more medicines within C08DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1312C, 1313D, 1335G, 8480H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504501201119315, 504501203111311, 504501303116315, 504501304112313, 504501403110319, 504501404117317
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 482448, 482455, 487553
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3988, 3989
Country: US	FDA, National Drug Code	Identifier(s): 0187-0771, 0187-0772, 0187-0792, 0187-0795, 0187-0796, 0187-0797, 0187-0798, 0187-0799, 0187-2045, 0187-2046, 0187-2047, 0187-2048, 0187-2049, 0187-2050